{"id":"W4402558664","doi":"10.1016/j.annonc.2024.08.2144","title":"987TiP First-in-human dose escalation trial of fourth generation chimeric antigen receptor (CAR) T cell therapy (EU307) in patients with glypican-3 (GPC3) positive hepatocellular carcinoma (HCC)","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Nexen (Canada)","funders":"","keywords":"Medicine; Glypican 3; Chimeric antigen receptor; Hepatocellular carcinoma; Oncology; Internal medicine; Cancer research; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005939741,0.0009465498,0.001591187,0.0003024332,0.0003620812,0.0009620673,0.000481607,0.001102689,0.005071835],"category_scores_gemma":[0.0004297221,0.000368289,0.0009064569,0.0002884843,0.0006863811,0.0007045997,0.0003384616,0.002704496,0.001248273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007283065,"about_ca_system_score_gemma":0.0007163389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006939456,"about_ca_topic_score_gemma":0.001503722,"domain_scores_codex":[0.9997463,0.0000887416,0.00001022866,0.00003554629,0.00001469448,0.0001045896],"domain_scores_gemma":[0.9997299,0.00004385074,0.00002229431,0.00003009814,0.000009444093,0.0001643849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8293446,0.03008982,0.005205882,0.0003266199,0.0007700691,0.0004417915,0.0002178706,0.003152932,0.02427327,0.0006236144,0.005058735,0.1004948],"study_design_scores_gemma":[0.5033469,0.4675727,0.01408672,0.00003281991,0.0003821638,0.0003821173,0.0001056015,0.002896652,0.005970097,0.0004860586,0.004689293,0.00004881751],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952989,0.0005263308,0.0002089106,0.0004138497,0.0001229291,0.0004761945,0.0005455569,0.00007851978,0.002328828],"genre_scores_gemma":[0.9937568,0.0004016828,0.0004632652,0.0006392944,0.00008742397,0.000549343,0.001097291,0.00002318399,0.002981767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005071835,"threshold_uncertainty_score":0.016967,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06382615843562044,"score_gpt":0.3500211554562919,"score_spread":0.2861949970206714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}